Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study

Hareth Nahi; Saad Zafar Usmani; Maria-Victoria Mateos; Niels W. C. J. van de Donk; Philippe Moreau; Albert Oriol; Torben Plesner; Shiyi Yang; Peter Hellemans; Brenda J. Tromp; Man (Melody) Luo; Donna Zemlickis; Andrew Farnsworth; Ajai Chari

doi:10.1200/JCO.2020.38.15_suppl.8537

Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study

Hareth Nahi, Saad Zafar Usmani, Maria-Victoria Mateos, Niels W. C. J. van de Donk, Philippe Moreau, Albert Oriol, Torben Plesner, Shiyi Yang, Peter Hellemans, Brenda J. Tromp, Man (Melody) Luo, Donna Zemlickis, Andrew Farnsworth, Ajai Chari

IRS - Sygehus Lillebælt, Forskningsenhed for Hæmatologi (Vejle)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	8537
Tidsskrift	Journal of Clinical Oncology
Vol/bind	38
Udgave nummer	Suppl. 15
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.2020.38.15_suppl.8537
Status	Udgivet - 20. maj 2020
Begivenhed	2020 ASCO Annual Meeting - Varighed: 29. maj 2020 → 31. maj 2020

Konference

Konference	2020 ASCO Annual Meeting
Periode	29/05/2020 → 31/05/2020

Dokumenter og links

10.1200/JCO.2020.38.15_suppl.8537

Citationsformater

Nahi, H., Usmani, S. Z., Mateos, M.-V., van de Donk, N. W. C. J., Moreau, P., Oriol, A., Plesner, T., Yang, S., Hellemans, P., Tromp, B. J., Luo, M., Zemlickis, D., Farnsworth, A., & Chari, A. (2020). Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study. Journal of Clinical Oncology, 38(Suppl. 15), Artikel 8537. https://doi.org/10.1200/JCO.2020.38.15_suppl.8537

@article{1d4e897d77b0407689fb3d41603a0d3a,

title = "Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study",

author = "Hareth Nahi and Usmani, {Saad Zafar} and Maria-Victoria Mateos and {van de Donk}, {Niels W. C. J.} and Philippe Moreau and Albert Oriol and Torben Plesner and Shiyi Yang and Peter Hellemans and Tromp, {Brenda J.} and Luo, {Man (Melody)} and Donna Zemlickis and Andrew Farnsworth and Ajai Chari",

year = "2020",

month = may,

day = "20",

doi = "10.1200/JCO.2020.38.15_suppl.8537",

language = "English",

volume = "38",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "Suppl. 15",

note = "2020 ASCO Annual Meeting ; Conference date: 29-05-2020 Through 31-05-2020",

}

Nahi, H, Usmani, SZ, Mateos, M-V, van de Donk, NWCJ, Moreau, P, Oriol, A, Plesner, T, Yang, S, Hellemans, P, Tromp, BJ, Luo, M, Zemlickis, D, Farnsworth, A & Chari, A 2020, 'Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study', Journal of Clinical Oncology, bind 38, nr. Suppl. 15, 8537. https://doi.org/10.1200/JCO.2020.38.15_suppl.8537

Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study. / Nahi, Hareth; Usmani, Saad Zafar; Mateos, Maria-Victoria et al.
I: Journal of Clinical Oncology, Bind 38, Nr. Suppl. 15, 8537, 20.05.2020.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study

AU - Nahi, Hareth

AU - Usmani, Saad Zafar

AU - Mateos, Maria-Victoria

AU - van de Donk, Niels W. C. J.

AU - Moreau, Philippe

AU - Oriol, Albert

AU - Plesner, Torben

AU - Yang, Shiyi

AU - Hellemans, Peter

AU - Tromp, Brenda J.

AU - Luo, Man (Melody)

AU - Zemlickis, Donna

AU - Farnsworth, Andrew

AU - Chari, Ajai

PY - 2020/5/20

Y1 - 2020/5/20

U2 - 10.1200/JCO.2020.38.15_suppl.8537

DO - 10.1200/JCO.2020.38.15_suppl.8537

M3 - Conference abstract in journal

SN - 0732-183X

VL - 38

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - Suppl. 15

M1 - 8537

T2 - 2020 ASCO Annual Meeting

Y2 - 29 May 2020 through 31 May 2020

ER -

Nahi H, Usmani SZ, Mateos MV, van de Donk NWCJ, Moreau P, Oriol A et al. Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study. Journal of Clinical Oncology. 2020 maj 20;38(Suppl. 15):8537. doi: 10.1200/JCO.2020.38.15_suppl.8537